Does lapatinib have potential in early management of progressive prostate cancer?

Posted on August 12, 2011 by Sitemaster

A recently published report of a Phase II clinical trial conducted by the Eastern Cooperative Oncology Group (ECOG) suggests that  the tyrosine kinase inhibitor (TKI) lapatinib (Tykerb) may have clinically significant effects in the treatment of men with progressive prostate cancer after first-line therapy. … READ MORE …

Filed under: Drugs in development, Management, Treatment | Tagged: | 3 Comments »

Tykerb not effective in treatment of prostate cancer

Posted on January 19, 2010 by Sitemaster

Like many other drugs before it, lapatinib (Tykerb/GlaxoSmithKline) appears to have very limited clinical activity in prostate cancer according to a recently published report. … READ MORE …

Filed under: Drugs in development | Tagged: , , | 2 Comments »